Variable | Odds ratio (95% CI) | P-value for overall effect | |
---|---|---|---|
Age | per 10 years increase | 2.32 (1.60, 3.34) | <0.001 |
Baseline HIV-1 RNA | per 1 log10 copies/mL increase | 0.46 (0.30, 0.71) | <0.001 |
Screening CD4 | per 100 cells/μL) increase | 0.66 (0.38,1.15) | 0.14 |
Hepatitis B surf. antigen | Positive vs. Negative | 2.86 (1.05, 7.77) | 0.040 |
Enrollment site | Harare Zimbabwe1 | 1 (reference site) | |
Botswana | 2.18 (0.60, 7.89) | 0.005 | |
Durban SA 2 | 2.96 (0.76, 11.57) | ||
Eldoret Kenya | 9.63 (3.01, 30.82) | ||
Kericho Kenya | 2.35 (0.63, 8.77) | ||
Johannesburg | SA2 1.15 (0.20, 6.55) | ||
Johannesburg | WITS3 SA2 2.97 (0.83,10.57) | ||
Lilongwe Malawi | 2.21 (0.55, 8.90) | ||
Kampala Uganda | 2.77 (0.75, 10.22) | ||
Lusaka Zambia | 5.05 (1.53, 16.67) |